Rigor Reviewed

Rigor-Reviewed Manuscript

Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition.

Name: Αlpha¹ Rigor Record — Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition.
Item: Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition.
Rating: 100
Author: Αlpha¹

Eichelmann F, Prada M, Sellem L, Jackson KG, Salas Salvadó J, Razquin Burillo C, Estruch R, Friedén M, Rosqvist F, Risérus U, Rexrode KM, Guasch-Ferré M, Sun Q, Willett WC, Martinez-Gonzalez MA, Lovegrove JA, Hu FB, Schulze MB, Wittenbecher C

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 1★ (Critical), 0 critical, 6 high issues for “Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 16, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

1 / 5

Critical — serious problems across many checks

Mixed Methods

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern ×5−2.5★
ClaimsEfficacy rests on an unvalidated surrogate endpoint−0.5★
ClaimsTreatment effect not shown to be clinically meaningful−0.5★
CitationsUnresolved reference−0.25★
LinksDead data/code link−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Problems surfaced7 types

Numerical inconsistencies1

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Internal contradictions in the reported numbersAssessed

Overstated conclusions3

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Efficacy rests on an unvalidated surrogate endpointAssessed
Treatment effect not shown to be clinically meaningfulAssessed
Conclusions only partially backed by the presented evidenceAssessed

Data authenticity concerns1

An adversarial read for patterns associated with data that may not be genuine: results that look too clean, implausibly large effects, duplicated data or images, and methods that do not match the results reported.

Other integrity concernAssessed

Broken references and links2

References checked against Crossref, OpenAlex and Retraction Watch for retractions and resolvability, plus declared data and code links probed for whether they resolve to content matching the paper.

Dead data/code linksRecomputed
References not resolvable to a published paperRecomputed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

The paper is methodologically strong, integrating an RCT with prospective cohorts and another RCT to derive and validate a lipidomics-based score. Reporting is generally transparent with detailed methods, ethics approvals, and data/code availability. Minor gaps include lack of explicit power analysis, outlier handling, and some threshold p-values.

Both reviewers classified the study as mixed, and this was adopted. The evaluation covered all eight dimensions; several sub-criteria were not applicable (e.g., animal-related items). The statistics verification recomputed only 4 tests, all consistent, but this does not validate the entire statistical analysis. The citation check flagged one reference not found in registry.

8 major claims checked against the paper's own evidence: 3 only partially supported (evidence backs part of the claim; gaps or caveats remain); the rest adequately supported.

Premise concern: surrogate not validated for clinical benefit; effect size not shown to be clinically meaningful.

Recomputed 4 tests: 4 consistent, 0 inconsistent; 4 via agent-written checks.

5 integrity concerns flagged (0 high).

Reporting

Eight Dimensions8 pass

The introduction cites WHO guidelines, evidence syntheses, and prior studies on dietary fat and cardiometabolic health, acknowledging controversies and gaps. The hypothesis that lipidome alterations interlink dietary fat substitution with disease risk is clearly stated and follows from the cited evidence. Limitations of prior research, such as confounding in observational studies and the need for RCT-based metabolite signatures, are addressed through the study's multi-design integration.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear scientific premise by citing prior research on dietary fat quality, lipidomics, and cardiometabolic risk, and provides a logical rationale for the study hypothesis.

Evidence

direct quote[Introduction, paragraph 1]

“The World Health Organization (WHO) recently issued dietary guidelines that advocate for reducing saturated fats while increasing unsaturated fats to prevent cardiometabolic diseases”